Medication info
Telmisartan 40/10 mg Tablet

Telmisartan 40/10 mg Tablet

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
K.S. Pharmaceutical Co., Ltd.
Appearance
Biconvex oval double tablet in white and light gray
Packaging
30 tablets/box [10 tablets/Alu-Alu X 3]
Approval status
Active

MFDS item code 201906301 · Approved 2019.09.04 · Insurance code 059000350

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before treatment with this medicine. However, a direct switch to this medicine may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Use with caution in the following patients’). In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
◦ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
K.S. Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or telmisartan. It helps effectively manage blood pressure, reducing the risk of cardiovascular diseases and improving health.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before treatment with this medicine. However, a direct switch to this medicine may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Use with caution in the following patients’). In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

◦ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication may cause serious harm to the fetus when used during pregnancy, especially in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with certain conditions, and those with liver impairment, heart disease, hypotension, kidney impairment, etc., should consult a doctor before use. Before using this medication, it is necessary to check for allergic reactions or hypersensitivity, and breastfeeding women should also refrain from taking this medicine. During usage, side effects such as dizziness or peripheral edema may occur, so caution is needed if these symptoms arise. Since this medication lowers blood pressure, patients with hypotension should carefully monitor their blood pressure status while taking it. Additionally, there is a risk of hyperkalemia, so regular checks on serum potassium levels are recommended. Patients with poor kidney function should regularly undergo kidney function tests while taking this medication. Interactions may occur when used with other blood pressure medications or drugs, so it is essential to inform about any medications currently being taken. This medication may cause drowsiness or dizziness, thus care should be taken while driving or operating hazardous machinery. In the event of an overdose, severe hypotension or heart problems may occur; therefore, adherence to the prescribed dose is crucial, and immediate medical attention is required if unusual symptoms arise. The safety and efficacy of this medication have not been sufficiently established for children or adolescents under 18 years of age, and its use is not recommended. Elderly patients may be more sensitive to the medication, necessitating dose adjustments and careful monitoring.

Side effects

  • Hypotension
  • neonatal craniosynostosis
  • anuria
  • renal failure
  • oligohydramnios
  • limb spasms
  • craniofacial malformation
  • pulmonary hypoplasia
  • premature birth
  • intrauterine growth restriction
Show 122 more
  • patent ductus arteriosus
  • dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • dysesthesia
  • hypoesthesia
  • dysgeusia
  • tremors
  • extrapyramidal disorder
  • hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver damage
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • kidney function impairment
  • voiding disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • epigastric discomfort
  • epigastric pain
  • positional dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer duration.

Appearance and packaging

Appearance

Biconvex oval double tablet in white and light gray

Package unit

30 tablets/box [10 tablets/Alu-Alu X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.